Improvement of the Selectivity Index (SI) and Cytotoxicity Activity of Doxorubicin Drug by Panax ginseng Plant Extract

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 155

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ARCHRAZI-76-3_025

تاریخ نمایه سازی: 6 دی 1402

چکیده مقاله:

In China, Japan, and Korea, Panax ginseng has been used in traditional medicine for thousands of years. Panax is a plant used as a general tonic or adaptogen for chronically ill patients. The current study evaluated the cytotoxicity of Panax ginseng extract (PGE). Different cell lines (HCT-۱۱۶, LNCaP, and normal cell line VERO) were treated with different inhibitory agentsat different concentrations (۱۰۰۰, ۵۰۰, ۲۵۰, ۱۲۵, ۶۲.۵, and ۳۱.۲۵ µg/ml) as follows: G۱ (Methanol Panax ginseng extract, PGE), G۲ (Doxorubicin, DOX), and G۳ (Methanol Panax ginseng extract +DOX, PDD). Each inhibitory agent group was used to treat the cancerous cell lines HCT-۱۱۶, LNCaP, and normal cell line (VERO) to obtain IC۵۰% by MTT assay. The inhibitory ability of the ۱۰۰۰ μg/ml PGE was significantly increased in all the three-cell lines compared with other concentrations. The recorded data revealed that the inhibition ability of PGE and Doxorubicin towards the HCT-۱۱۶ cell line significantly increased compared with the other cell lines. The interaction between different PGE concentrations and cell lines showed that the ۱۰۰۰ μg/ml PEG had the highest inhibitory effects on HCT-۱۱۶ compared with other combinations. The interaction between different DOX concentrations and different types of cell lines showed that the ۱۰۰۰ μg/ml DOX had the highest inhibitory effects on LNCap compared with other combinations. The PGD inhibition ability reflected a significantly higher difference toward the HCT-۱۱۶ cell line as compared with other cell lines. IC۵۰% is the concentrations (µg/ml) to kill ۵۰% of cell line. It was calculated by MTT assay for three cell lines: HCT-۱۱۶, LNCaP, and VERO. The rate of effectiveness of the inhibitory factors (PGE, DOX, and PGD) showed highly significant differences toward the cell line HCT-۱۱۶ compared to the other cell lines. This indicates the safety of the PGE compound and its low toxicity toward normal cells, quite the opposite of cancer cells as compared to the common drug DOX and combined PGD (PGE+DOX). PGD combined with DOX (PGE + DOX) showed antagonistic results toward the HCT۱۱۶, LNCaP, and VERO cell lines, while UDE combined with DOX (UDE+DOX) showed synergistic activity.

نویسندگان

M Radha Abbas Hasoon

University of Kufa, Faculty of Science, Department of Biology, Iraq

N Jawad Kadhim

University of Kufa, Faculty of Science, Department of Biology, Iraq

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Jung MY, Jeon BS, Bock JY. Free, esterified, and insoluble-bound ...
  • Baeg IH, So SH. The world ginseng market and the ...
  • Scholar G. Ministry_of_AgricultureFaRA, Ginseng Statistical Data (No. ۱۱-۱۵۴۳۰۰۰-۰۰۰۰۰۴-۱۰) Ministry of ...
  • Kwok HH, Ng WY, Yang MS, Mak NK, Wong RN, ...
  • Naval MV, Gomez-Serranillos MP, Carretero ME, Villar AM. Neuroprotective effect ...
  • Song X, Chen J, Sakwiwatkul K, Li R, Hu S. ...
  • Wang CZ, Mehendale SR, Yuan CS. Commonly used antioxidant botanicals: ...
  • Y.G. Gao, P. Zang, J.X. Hao, P. Li, X. Li, ...
  • Buys SS, Partridge E, Black A, Johnson CC, Lamerato L, ...
  • Sweilem HbA. Implications of the use of collateral and their ...
  • Almowafy R, Taha YA. Monthly Archives۲۰۱۳ ...
  • Homady MH, Kadhim HA, Al-Kelaby KKA, Aziz DZ, Kadhim NJ. ...
  • Remesh A. Toxicities of anticancer drugs and its management. Int ...
  • Konstat-Korzenny E, Ascencio-Aragon JA, Niezen-Lugo S, Vazquez-Lopez R. Artemisinin and ...
  • Ali M, Abbasi BH, Ahmad N, Khan H, Ali GS. ...
  • Hashym QM, Al-Zahra JMA, Kadhim NJ. Reducing the Heart Biochemical ...
  • Bakrania K, Edwardson CL, Bodicoat DH, Esliger DW, Gill JM, ...
  • Kadhim NJ, Al-Rekaby LS, Redha AA, J. C. Chemical composition ...
  • Barrera G. Oxidative stress and lipid peroxidation products in cancer ...
  • Wang Z, Mi, H., Hamza W, Florian R. Multi-perspective context ...
  • Tong P, Coombes KR, Johnson FM, Byers LA, Diao L, ...
  • Chen S, Wang Z, Huang Y, O'Barr SA, Wong RA, ...
  • Klempner SJ, Bubley G. Complementary and alternative medicines in prostate ...
  • McDermott CL, Blough DK, Fedorenko CR, Arora NK, Zeliadt SB, ...
  • Sartiano GP, Lynch WE, Bullington WD. Mechanism of action of ...
  • Effenberger-Neidnicht K, Schobert R. Combinatorial effects of thymoquinone on the ...
  • Park HH, Choi SW, Lee GJ, Kim YD, Noh HJ, ...
  • Kim SM, Lee SY, Cho JS, Son SM, Choi SS, ...
  • Kim SM, Lee SY, Yuk DY, Moon DC, Choi SS, ...
  • Gu C, Qiao J, Zhu M, Du J, Shang W, ...
  • B. X. Wang, J. C. Cui, A. J. Liu. The ...
  • Du XF, Jiang CZ, Wu CF, Won EK, Choung SY. ...
  • Liu TG, Huang Y, Cui DD, Huang XB, Mao SH, ...
  • Zhang Q, Kang X, Zhao W. Antiangiogenic effect of low-dose ...
  • Ge M, Fang YY, Liu GP, Guan SD. Effect of ...
  • Chen Z, Wang P, Huang WX, Liu LM. [Experimental study ...
  • Che CT, Wang ZJ, Chow MS, Lam CW. Herb-herb combination ...
  • Z. J. Wang, C. Xie, Y. Huang, C. W. K. ...
  • Hu Z, Yang X, Ho PC, Chan SY, Heng PW, ...
  • Sun H, Liu XD, Liu Q, Wang FP, Bao XQ, ...
  • Abdallah HM, Al-Abd AM, El-Dine RS, El-Halawany AM. P-glycoprotein inhibitors ...
  • Lai GM, Chen YN, Mickley LA, Fojo AT, Bates SE. ...
  • S. Helms. Cancer prevention and therapeutics: Panax ginseng. Alternative Medicine ...
  • نمایش کامل مراجع